...
首页> 外文期刊>Biotechnology Journal: Healthcare,Nutrition,Technology >Plasmid Copy Number of pTRKH3 in Lactococcus lactis is Increased by Modification of the repDE Ribosome‐Binding Site
【24h】

Plasmid Copy Number of pTRKH3 in Lactococcus lactis is Increased by Modification of the repDE Ribosome‐Binding Site

机译:通过改性核糖核糖体结合位点,增加了乳球菌乳酸中PTRKH3的质粒拷贝数

获取原文
获取原文并翻译 | 示例
           

摘要

> Plasmids for DNA vaccination are exclusively produced in the Gram‐negative Escherichia coli . One important drawback of this system is the presence of lipopolysaccharides. The generally recognized as safe Lactococcus lactis ( L. lactis ) would constitute a safer alternative for plasmid production. A key requirement for the establishment of a cost‐effective L. lactis ‐based plasmid manufacturing is the availability of high‐copy number plasmids. Unfortunately, the highest copy number reported in Gram‐positive bacteria for the pAMβ1 replicon is around 100 copies. The purpose of this work is to engineer the repDE ribosome‐binding site (RBS) of the pTRKH3 plasmid by site‐directed mutagenesis in order to increase the plasmid copy number in L. lactis LMG19460 cells. The pTRKH3‐b mutant is the most promising candidate, achieving 215 copies of plasmid per chromosome, a 3.5‐fold increase when compared to the nonmodified pTRKH3, probably due to a stronger RBS sequence, a messenger RNA secondary structure that promotes the RepDE expression, an ideal intermediate amount of transcriptional repressors and the presence of a duplicated region that added an additional RBS sequence and one new in‐frame start codon. pTRKH3‐b is a promising high‐copy number shuttle plasmid that will contribute to turn lactic acid bacteria into a safer and economically viable alternative as DNA vaccines producers.
机译: > 用于DNA疫苗接种的质粒完全在革兰氏阴性中产生 大肠杆菌 。该系统的一个重要缺点是存在脂多糖。通常被认为是安全的 乳球菌乳酸乳酸 - / i> ( l。 Lactis )将构成质粒生产的更安全的替代品。建立成本效益的关键要求 l。 Lactis 基于质粒制造是高拷贝数质粒的可用性。不幸的是,PAMβ1复制子的革兰氏阳性细菌报告的最高拷贝数是100份拷贝。这项工作的目的是工程师 repde 通过定向诱变的PTRKH3质粒的核糖体结合位点(RBS),以增加质粒拷贝数 l。 Lactis LMG19460细胞。 PTRKH3-B突变体是最有前途的候选者,达到每条染色体的215份质粒拷贝,与非制定的PTRKH3相比,3.5倍的增加,可能是由于RBS序列较强,促进了REPDE表达的信使RNA二级结构,一种理想的转录阻遏物的中间量和加入另外的RBS序列的重复区域和一个新的内框架起始密码子。 PTRKH3-B是一个有前途的高拷贝数梭子质粒,有助于将乳酸菌转化为更安全和经济上可行的替代品,作为DNA疫苗生产商。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号